#Vietnam – Page 3 – HEALTHCARE INSIGHTS

Key Development On August 22, 2026, Vietnam’s Ministry of Health issued Decision No. 2684/QĐ-BYT withdrawing AstraZeneca Vietnam’s pharmaceutical business eligibility... Read more

Tag: #Vietnam

Health Insurance Medical Device Formulary: Vietnam MOH Refines Draft Circular Prioritizing Feasibility, Transparency, and Digital Interoperability

Quality Control & Regulatory Enforcement: Drug Administration of Vietnam Fines Pharmedic VND 50 Million for Class 3 Quality Defect in Sodium Chloride 0.9% Eye Drops Failing Clarity Standards

Biopharmaceutical Supply Chain Realignment: AstraZeneca Vietnam Voluntarily Relinquishes Legacy Warehouse License to Commission Modernized Logistics Infrastructure Amid Financial Expansion and 2027–2029 Localization Roadmaps

Macro Healthcare Economics & Pricing Controls: Vietnam Pharmaceutical and Healthcare CPI Expands 1.24% YoY Driven by Imported API and Logistics Costs – Ministry of Health Enforces Hospital Retail Margin Caps

Pharma Corporate Governance & Equity Realignment: Vidipha Chairman (HoSE: VDP) and Family Members Divest Entire ~30% Equity Stake on His 78th Birthday

Healthcare Governance & Administrative Compliance: Ministry of Health Convenes Northern Regional Training on Citizen Reception, Dispute Resolution, and Anti-Corruption Oversight

Accelerating National Healthcare Digital Transformation: Ministry of Health Expands Electronic Medical Records (EMR) Across 1,263 Hospitals and Integrates Over 34 Million Electronic Health Records on VNeID

Urban Primary Healthcare Reform: Ho Chi Minh City Department of Health Proposes 3-to-5-Year Secondment of Hospital Physicians as Community Health Station Directors to Anchor Multi-Tiered Healthcare Integration

ASTRAZENECA VIETNAM’S LOGISTICS TRANSITION SIGNALS A BROADER PHARMA SHIFT

Facebook

Map

Online Members